| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant ecotropic viral integration site-1 (EVI-1) and myocyte enhancer factor 2 C gene (MEF2C) in adult acute myeloid leukemia are associated with adverse t (9:22) & 11q23 rearrangements
|
Menshawy, Nadia El
|
|
|
103 |
7 |
p. 2355-2364
|
artikel
|
| 2 |
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy
|
Iovene, Francesca Romana
|
|
|
103 |
7 |
p. 2545-2549
|
artikel
|
| 3 |
A new score for predicting intracranial hemorrhage in patients using antiplatelet drugs
|
Ma, Fuxin
|
|
|
103 |
7 |
p. 2511-2521
|
artikel
|
| 4 |
BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL
|
Wang, Ruiqi
|
|
|
103 |
7 |
p. 2455-2462
|
artikel
|
| 5 |
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL)
|
Braun, Adam
|
|
|
103 |
7 |
p. 2541-2543
|
artikel
|
| 6 |
Challenges in the management of iron-deficiency anemia in Senegal, West Africa
|
Seck, Moussa
|
|
|
103 |
7 |
p. 2565-2567
|
artikel
|
| 7 |
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients
|
Shi, Yu
|
|
|
103 |
7 |
p. 2323-2335
|
artikel
|
| 8 |
Development of a target concentration intervention to individualize paroxysmal nocturnal hemoglobinuria treatment with pegcetacoplan
|
ter Avest, Mendy
|
|
|
103 |
7 |
p. 2267-2272
|
artikel
|
| 9 |
DNT cells mediate resistance to CAR-T cells therapy in a pediatric patient with relapsed and refractory B-ALL
|
Chen, Ruotong
|
|
|
103 |
7 |
p. 2551-2556
|
artikel
|
| 10 |
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity
|
Di Staso, Rossana
|
|
|
103 |
7 |
p. 2499-2509
|
artikel
|
| 11 |
Efficacy and safety of new-generation Bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia/small lymphocytic lymphoma: a systematic review and meta-analysis
|
Yin, Shuo
|
|
|
103 |
7 |
p. 2231-2244
|
artikel
|
| 12 |
2-[18]F FDG PET/CT dissemination features in adult burkitt lymphoma Are predictive of outcome
|
Albano, Domenico
|
|
|
103 |
7 |
p. 2419-2427
|
artikel
|
| 13 |
Genetic and prognostic analysis of blastoid and pleomorphic mantle cell lymphoma: a multicenter analysis in China
|
Yang, Ping
|
|
|
103 |
7 |
p. 2381-2391
|
artikel
|
| 14 |
High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China
|
Zhang, Zhiyu
|
|
|
103 |
7 |
p. 2337-2346
|
artikel
|
| 15 |
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies
|
Cordón, Lourdes
|
|
|
103 |
7 |
p. 2475-2484
|
artikel
|
| 16 |
Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type
|
Choi, Soyeon
|
|
|
103 |
7 |
p. 2429-2443
|
artikel
|
| 17 |
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia
|
Cui, Tong
|
|
|
103 |
7 |
p. 2463-2473
|
artikel
|
| 18 |
Leukemia and mitophagy: a novel perspective for understanding oncogenesis and resistance
|
Liu, Yueyao
|
|
|
103 |
7 |
p. 2185-2196
|
artikel
|
| 19 |
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura
|
Mulas, Olga
|
|
|
103 |
7 |
p. 2523-2531
|
artikel
|
| 20 |
Mendelian randomization of circulating proteome identifies IFN-γ as a druggable target in aplastic anemia
|
Qin, Shanshan
|
|
|
103 |
7 |
p. 2245-2256
|
artikel
|
| 21 |
Myeloid sarcoma with RAM phenotype in an adult male presenting with CNS relapse; no longer a pediatric disease
|
Panda, Devasis
|
|
|
103 |
7 |
p. 2561-2563
|
artikel
|
| 22 |
Nomogram predictive models for adult patients with acute lymphoblastic leukaemia based on real-world treatment outcomes
|
Chen, Yi
|
|
|
103 |
7 |
p. 2393-2404
|
artikel
|
| 23 |
Novel methyltransferase G9a inhibitor induces ferroptosis in multiple myeloma through Nrf2/HO-1 pathway
|
Zhang, Yu
|
|
|
103 |
7 |
p. 2405-2417
|
artikel
|
| 24 |
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated acute myeloid leukemia
|
Lap, Coen J
|
|
|
103 |
7 |
p. 2215-2229
|
artikel
|
| 25 |
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes
|
Palandri, Francesca
|
|
|
103 |
7 |
p. 2347-2354
|
artikel
|
| 26 |
Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis
|
Yi, Jun Ho
|
|
|
103 |
7 |
p. 2365-2372
|
artikel
|
| 27 |
Revisiting iron overload status and change thresholds as predictors of mortality in transfusion-dependent β-thalassemia: a 10-year cohort study
|
Musallam, Khaled M.
|
|
|
103 |
7 |
p. 2283-2297
|
artikel
|
| 28 |
Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation
|
Tong, Ke
|
|
|
103 |
7 |
p. 2485-2497
|
artikel
|
| 29 |
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group
|
Scheubeck, Gabriel
|
|
|
103 |
7 |
p. 2373-2380
|
artikel
|
| 30 |
Role of brentuximab vedotin plus sirolimus in the treatment of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder: a case-based review
|
Zhou, Kuangguo
|
|
|
103 |
7 |
p. 2207-2213
|
artikel
|
| 31 |
ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options
|
Kiladjian, Jean-Jacques
|
|
|
103 |
7 |
p. 2299-2310
|
artikel
|
| 32 |
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial
|
Mei, Heng
|
|
|
103 |
7 |
p. 2273-2281
|
artikel
|
| 33 |
The clinical significance and prognostic value of serum beta-2 microglobulin in adult lymphoma-associated hemophagocytic lymphohistiocytosis: a multicenter analysis of 326 patients
|
Jin, Ze
|
|
|
103 |
7 |
p. 2257-2266
|
artikel
|
| 34 |
The critical role of endothelial cell in the toxicity associated with chimeric antigen receptor T cell therapy and intervention strategies
|
Zhang, Qi
|
|
|
103 |
7 |
p. 2197-2206
|
artikel
|
| 35 |
Tixagevimab/cilgavimab (AZD7442/Evusheld) prevent from COVID19 in patients with hematologic malignancies under active chemotherapy
|
Lee, Yoo Jin
|
|
|
103 |
7 |
p. 2533-2539
|
artikel
|
| 36 |
Treatment of primary cardiac diffuse large B-cell lymphoma involving the coronary sinus with R-EPOCH: a case report and literature review
|
Rezvani, Aryan
|
|
|
103 |
7 |
p. 2557-2560
|
artikel
|
| 37 |
Upfront allogeneic hematopoietic stem cell transplantation for adult T-cell acute lymphoblastic leukemia/lymphoma in first complete remission: a single-center study
|
Gu, Zhenyang
|
|
|
103 |
7 |
p. 2445-2454
|
artikel
|
| 38 |
XPO1 inhibition displays anti-leukemia efficacy against DNMT3A-mutant acute myeloid leukemia via downregulating glutathione pathway
|
Cai, Xiaoya
|
|
|
103 |
7 |
p. 2311-2322
|
artikel
|
Tijdschrift beschrijving